Ubs Group Ag Emergent Bio Solutions Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Ubs Group Ag holds 483,980 shares of EBS stock, worth $4.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
483,980
Previous 579,396
16.47%
Holding current value
$4.79 Million
Previous $2.82 Million
9.66%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding EBS
# of Institutions
187Shares Held
39.2MCall Options Held
299KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$38 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$35.7 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$35.4 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$22.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$18.3 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $493M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...